Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L Hauser

Showing results (81-90 of 322) with videos related to

Pageof 33
Sort By:
Annals of Neurology|October 31, 2012
Healthcare costs: Eden's apple?S Claiborne Johnston, Stephen L Hauser
The New England Journal of Medicine|April 27, 2017
Ocrelizumab in Primary Progressive and Relapsing Multiple SclerosisStephen L Hauser, Shibeshih Belachew, Ludwig Kappos
Annals of Neurology|June 29, 2019
Reply to "Silent Progression or Bout Onset Progressive Multiple Sclerosis?"Bruce A C Cree, Stephen L Hauser
The American Journal of Medicine|July 20, 2020
Treatment of Multiple Sclerosis: A ReviewStephen L Hauser, Bruce A C Cree
Nature Medicine|April 9, 2011
Enhancing ties between academia and industry to improve healthS Claiborne Johnston, Stephen L Hauser, Susan Desmond-Hellmann
Annals of Neurology|May 4, 2010
Neuroreconciliation and the health care debateStephen L Hauser, S Claiborne Johnston, Adam F Stewart
Annals of Neurology|April 19, 2013
Multiple sclerosis: monotherapy rulesStephen L Hauser, S Andrew Josephson, S Claiborne Johnston
Annals of Neurology|March 13, 2010
Getting youth in the game: can we accelerate training for clinician-scientists?Stephen L Hauser, Daniel H Lowenstein, S Claiborne Johnston
Annals of Neurology|January 3, 2013
Electronic medical records and the academic neurologist: when carrots turn into sticksS Andrew Josephson, S Claiborne Johnston, Stephen L Hauser
Annals of Neurology|October 12, 2013
Blockbusters for cheap? The difficulties surrounding generic biologicsS Andrew Josephson, S Claiborne Johnston, Stephen L Hauser
Pageof 33

Showing results (81-90 of 322) with videos related to

Sort By:
Pageof 33
Annals of Neurology|October 31, 2012
Healthcare costs: Eden's apple?S Claiborne Johnston, Stephen L Hauser
The New England Journal of Medicine|April 27, 2017
Ocrelizumab in Primary Progressive and Relapsing Multiple SclerosisStephen L Hauser, Shibeshih Belachew, Ludwig Kappos
Annals of Neurology|June 29, 2019
Reply to "Silent Progression or Bout Onset Progressive Multiple Sclerosis?"Bruce A C Cree, Stephen L Hauser
The American Journal of Medicine|July 20, 2020
Treatment of Multiple Sclerosis: A ReviewStephen L Hauser, Bruce A C Cree
Nature Medicine|April 9, 2011
Enhancing ties between academia and industry to improve healthS Claiborne Johnston, Stephen L Hauser, Susan Desmond-Hellmann
Annals of Neurology|May 4, 2010
Neuroreconciliation and the health care debateStephen L Hauser, S Claiborne Johnston, Adam F Stewart
Annals of Neurology|April 19, 2013
Multiple sclerosis: monotherapy rulesStephen L Hauser, S Andrew Josephson, S Claiborne Johnston
Annals of Neurology|March 13, 2010
Getting youth in the game: can we accelerate training for clinician-scientists?Stephen L Hauser, Daniel H Lowenstein, S Claiborne Johnston
Annals of Neurology|January 3, 2013
Electronic medical records and the academic neurologist: when carrots turn into sticksS Andrew Josephson, S Claiborne Johnston, Stephen L Hauser
Annals of Neurology|October 12, 2013
Blockbusters for cheap? The difficulties surrounding generic biologicsS Andrew Josephson, S Claiborne Johnston, Stephen L Hauser
Pageof 33